Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06403345
Other study ID # 22206
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 29, 2024
Est. completion date November 30, 2024

Study information

Verified date May 2024
Source Indiana University
Contact Rebecca Lassell, PhD
Phone 812-855-2395
Email blassell@iu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the Green Activity Program that was designed with Hispanic/Latino people living with memory challenges and their study partners to see if it can be done and if they enjoy the program. "Green activities" are nature activities that the person enjoys and can be done with other people or pets. For example, dog walking, hiking, outdoor yoga, and gardening are all green activities. The purpose of the program is to help people living with memory challenges participate in nature activities they enjoy. The goal of the program is to help people stay active and improve their health and well-being.


Description:

This is a single arm pre/post feasibility study lasting up to 1 year. Investigators will recruit in n=40 dyads (Hispanic/Latino people living with memory challenges and their study partners n=80 total) and expect n=30 (n=60 total people living with memory challenges and study partners) to complete the 12-week GAP-H and evaluate it for feasibility and acceptability. Anonymous program evaluation surveys will be administered either via paper or RedCap survey to the outdoor activity professionals who participated in the study. Brief recorded phone interviews (5 minutes) will be conducted with the people living with memory challenges and their study partners after the intervention and 15-minute brief calls with the outdoor activity professionals will be used to gather feedback to refine the program. Informal conversations with the occupational therapist(s) delivering the intervention will occur to identify areas for refinement and will be documented with anonymous notes and no identifiable data collected from them. Sustained behavior change will be measured in people living with memory challenges at 4 weeks after the intervention.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date November 30, 2024
Est. primary completion date October 30, 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - 60 years or older - Identify as Hispanic/Latino - Speaks Spanish or English - T-MoCA scores 13-19 - Capacity to provide informed consent - Have access and ability to respond to the telephone (mobile or landline) Study partner - 18 years or older - Identify as Hispanic/Latino - Speaks Spanish or English - Identified by the PLMC as a person they feel comfortable with who they would like to join them in the study. The study partner's participation is based on level of support needed for the PLMC. Outdoor activity professionals - 18 years or older - at least 1 year experience providing outdoor activities Exclusion Criteria: - Participants living with memory challenges will be excluded if they do not meet inclusion criteria or if they indicate any of the following on the 2023 Physical Activity Readiness Questionnaire + (PAR-Q+) - Heart failure or difficulty controlling Coronary Artery Disease, Diagnosed Abnormality of Heart Rhythm, or other cardiovascular condition. - Cancer and are actively receiving therapies - Experienced a black out, fainted, or lost consciousness as a result of a head injury in the past 12 months. - Often experienced signs and symptoms of low blood sugar (hypoglycemia) following exercise and/or daily activities. - >3 hospitalizations

Study Design


Intervention

Behavioral:
Green Activity Program
See arm description.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Indiana University American Federation for Aging Research

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility intervention completion rate intervention completion rate of 75% Through study completion
Primary Other Feasibility measures 75% attendance, 75% retention, intervention fidelity using a checklist by an outside rater with at least 75% of potential active ingredients present in 25% of randomly sampled sessions: tailoring (environment, activity, personalized delivery), behavioral activation, and nature (outdoor environment or incorporating nature [plant or animal]). Feasibility data of recruitment rates (eligible participants/# recruited per month), feasibility of assessments (time to complete, with an 80% completion rate) will be collected, and we will also track missing data. Through study completion
Primary Acceptability Two selected questions from the Intervention Tolerability scale will be asked to the person living with memory challenges over the phone: "The program was easy to use" and "I liked this program." Rated by (yes/no). We expect at least 70% of people living with memory challenges will be satisfied with the intervention (yes to both questions). Up to one month after the 12-week program.
Secondary Goal Attainment Scaling Primary goal met (yes/no) Up to one month after the 12-week program
Secondary Quick Physical Activity Scale Physical activity Up to 1 month before and after the 12-week program
Secondary Heart Rate ActiGraph LEAP 1 week pre 12-week program and 1 week post
Secondary Physical activity ActiGraph LEAP 1 week pre 12-week program and 1 week post
Secondary Sedentary time ActiGraph LEAP 1 week pre 12-week program and 1 week post
Secondary Health Patient-Reported Outcomes Measurement Information System: Physical health. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Well-being Patient-Reported Outcomes Measurement Information System: Mental Health. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Social Participation Patient-Reported Outcomes Measurement Information System: Satisfaction with participation in social activities. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Depression Geriatric Depression Scale short form, Up to 1 month before and after the 12-week program
Secondary Sleep quality Pittsburgh Sleep Quality Index Up to 1 month before and after the 12-week program
Secondary Sleep ActiGraph LEAP 1 week before and 1 week after the 12 week intervention
Secondary UCLA 3-item Loneliness scale Loneliness Up to 1 month before and after the 12-week program
Secondary Neuropsychiatric symptoms Neuropsychiatric symptoms questionnaire Up to 1 month before and after the 12-week program
Secondary Brief phone interviews 2 -Post questions over the phone: "What did you like about the program? What would you change?" Up to 1 month after the 12-week program
Secondary Study Partner Health Patient-Reported Outcomes Measurement Information System: Physical health. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Study Partner well-being Patient-Reported Outcomes Measurement Information System: Mental Health. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Study Partner Social Participation Patient-Reported Outcomes Measurement Information System: Satisfaction with participation in social activities. Scored on the T-score metric. High scores mean more of the concept being measured.
A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population.
Up to 1 month before and after the 12-week program
Secondary Study Partner Depression Geriatric Depression Scale short form Up to 1 month before and after the 12-week program
Secondary Feasibility for Study partner Feasibility of an Intervention Measure Up to 1 month after the 12-week program
Secondary Acceptability for Study Partner Acceptability of an Intervention Measure Up to 1 month after the program
Secondary Appropriateness for Study Partner Appropriateness of an Intervention Measure Up to 1 month after the 12-week program
Secondary Brief phone interview "What did you like about the program? What would you change?" Up to 1 month after the 12-week program
Secondary Outdoor Professional Dementia Knowledge Dementia Knowledge Assessment Up to 1 month before and after the dementia training
Secondary Outdoor Professional strategies for tailoring activities Strategies for Tailoring Activities quiz Up to 1 month before and after the strategy training
Secondary Outdoor Professional brief phone interview 15-minute brief phone interview post Up to 2 weeks after the 12 week program
Secondary Sustained Behavior Change for People Living with Memory Challenges 3 Questions asked via phone
Are you still doing the activities?
(If yes) Do you plan to continue doing the activities? (If no) Why not? Do plan to do them in the future?
Have you added any new activities?
1 month after the 12 week program
Secondary Cognitive function T-MoCa Up to 1 month before and after 12 week program
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A